matter.farm

Computer-generated molecule database for public drug discovery. About this project.

These compounds may interact with:

Bone morphogenetic protein 1

Potentially involved in: osteogenesis imperfecta; carcinoma; dentinogenesis imperfecta; retinitis pigmentosa 43; trichorhinophalangeal syndrome type ii; epidermolysis bullosa dystrophica; umbilical hernia; muscle degeneration; osteogenesis imperfecta type iii (disorder); neurogenic muscular atrophy; skeletal muscle atrophy; triangular face; neurogenic muscle atrophy, especially in the lower limbs; platyspondyly; osteogenesis imperfecta, type xiii; autosomal recessive predisposition; osteogenesis imperfecta, type 13; osteogenesis imperfecta type 3; active crohn's disease; atypical teratoid / rhabdoid tumor

Disease data sourced from Pharos.

Unknown Action